Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lung Fung Group Holdings (HKSE:02290) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Lung Fung Group Holdings EPS (Diluted) Related Terms
Lung Fung Group Holdings EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Fung Group Holdings EPS (Diluted) Chart
Lung Fung Group Holdings Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
EPS (Diluted)
-0.05
0.29
0.34
0.54
Lung Fung Group Holdings Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
EPS (Diluted)
-0.05
0.29
0.34
0.54
HKSE:02290 vs DDS: EPS (Diluted) Comparison
For the Department Stores subindustry, Lung Fung Group Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lung Fung Group Holdings PE Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Lung Fung Group Holdings's PE Ratio distribution charts can be found below:
* The bar in red indicates where Lung Fung Group Holdings's PE Ratio falls into.
Lung Fung Group Holdings EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Lung Fung Group Holdings's Diluted EPS for the fiscal year that ended in Mar. 2026 is calculated as
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lung Fung Group Holdings (HKSE:02290) has a EPS (Diluted) of HK$0.54 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Lung Fung Group Holdings and its competitors.
Is Lung Fung Group Holdings' EPS (Diluted) too high?
Lung Fung Group Holdings' current EPS (Diluted) is HK$0.54. Overall, Lung Fung Group Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Lung Fung Group Holdings' EPS (Diluted) compare to DDS?
Lung Fung Group Holdings' EPS (Diluted) of HK$0.54 can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Retail - Cyclical company?
A good EPS (Diluted) depends on the Retail - Cyclical industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Lung Fung Group Holdings and its competitors. Lung Fung Group Holdings's current EPS (Diluted) is HK$0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lung Fung Group Holdings stock overvalued right now?
Lung Fung Group Holdings (HKSE:02290) has a current EPS (Diluted) of HK$0.54. The current EPS (Diluted) is HK$0.54. Lung Fung Group Holdings' overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Lung Fung Group Holdings (HKSE:02290), the current EPS (Diluted) is HK$0.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lung Fung Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates as a Hong Kong-based chain retail store of beauty, health and pharmaceutical products under the 'Lung Fung' brand. It principally engaged in the sales of a wide variety of beauty products, health products, pharmaceutical products and other consumer goods such as household and daily essentials and food products. The majority of revenue is derived from the sales of Beauty products through retail stores located in Hong Kong.
17GF Score
Get the complete analysis for HKSE:02290
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02290 has been successfully added to your 
